Cargando…
Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer’s Disease
Background: Cholinesterase inhibitors such as donepezil are used in the treatment of Alzheimer’s disease. Patients taking cholinesterase inhibitors can develop cholinergically mediated QT prolongation, which may lead to life-threatening arrhythmias. In this study we investigated the corrected QT int...
Autores principales: | Kuwahata, So, Takenaka, Toshihiro, Motoya, Toshiro, Masuda, Keisuke, Yonezawa, Hideyuki, Shinchi, Shuya, Kawashima, Yoshihiro, Mohri, Shogo, Ohishi, Mitsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956884/ https://www.ncbi.nlm.nih.gov/pubmed/33738343 http://dx.doi.org/10.1253/circrep.CR-20-0115 |
Ejemplares similares
-
Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential ― Reply ―
por: Kuwahata, So, et al.
Publicado: (2021) -
QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020) -
Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
por: Green, Keith D., et al.
Publicado: (2018) -
Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel
por: Li, Kai, et al.
Publicado: (2017) -
Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly
por: Thamban Chandrika, Nishad, et al.
Publicado: (2019)